Platelet-rich plasma injections for hip osteoarthritis: a review of the evidence
- PMID: 33015749
- DOI: 10.1007/s11845-020-02388-z
Platelet-rich plasma injections for hip osteoarthritis: a review of the evidence
Abstract
Osteoarthritis is a significant cause of chronic pain in the elderly population with hip osteoarthritis as one of the main causes of functional disability and joint pain in adults older than 55 years. Recently, platelet rich plasma (PRP) injections have been introduced for treatment of osteoarthritis. The aim of this systematic review is to assess its effectiveness in the management of hip osteoarthritis. We performed a search of the literature for published prospective studies that assessed the effectiveness of PRP injections in the treatment of hip osteoarthritis, with a minimum follow-up of 3 months. Primary outcome measures were WOMAC and VAS scores. Five trials were identified with 185 patients undergoing treatment with ultrasound-guided intra-articular injections of PRP, compared with patients treated with hyaluronic acid alone (n = 148) or hyaluronic acid combined with PRP (n = 31) in one study. PRP was shown to improve patient outcome scores at follow-up at 6 and 12 months; however, there was no significant difference seen between patients treated with PRP or hyaluronic acid alone. Following this systematic review, we cannot currently recommend the use of intra-articular injections of PRP for the treatment of hip OA. Given that intra-articular steroid injections are the only such injection recommended by international guidelines for the treatment of hip OA, further studies comparing PRP to steroid would be of benefit to determine the value of PRP injections in hip OA.
Keywords: Cartilage; Orthopaedic; Osteoarthritis; PRP; Platelet-rich plasma.
© 2020. Royal Academy of Medicine in Ireland.
References
-
- Song J, Chang RW, Dunlop DD (2006) Population impact of arthritis on disability in older adults. Arthritis Rheum 55(2):248–255 - DOI
-
- Roux CH, Saraux A, Mazieres B et al (2008) Screening for hip and knee osteoarthritis in the general population: predictive value of a questionnaire and prevalence estimates. Ann Rheum Dis 67(10):1406–1411 - DOI
-
- Hochberg MC, Altman RD, Brandt KD et al (1995) Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum 38(11):1541–1546 - DOI
-
- Richy F, Bruyere O, Ethgen O et al (2004) Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Rheum Dis 63(7):759–766 - DOI
-
- McCabe PS, Maricar N, Parkes MJ et al (2016) The efficacy of intra-articular steroids in hip osteoarthritis: a systematic review. Osteoarthr Cartil 24(9):1509–1517 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
